Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 1

1(25.0%)

4Total

N/A(3)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT01172860Phase 1Completed

Endoscopic Treatment of Inoperable Colorectal Cancer With the EndoVe System

Role: collaborator

NCT02356601Completed

Lumbar Neuraxial Ultrasound Corrrelation With MRI

Role: lead

NCT01665742Not ApplicableCompleted

Anti-inflammatory Dietary Intervention in Overweight and Obese Adolescents

Role: collaborator

NCT02041806Unknown

Assessing Peripheral Nerve Block Scoring Systems for Intra-Operative and Post-Operative Analgesia

Role: lead

NCT01189669Not ApplicableCompleted

n-3 Polyunsaturated Fatty Acids (PUFA) Supplementation in Young Women With Polycystic Ovary Syndrome (PCOS)

Role: lead

NCT01195142Completed

Adipose Tissue Gene Expression Profiles in Women With Polycystic Ovary Syndrome (PCOS) Versus Controls

Role: lead

NCT01195168Completed

Cardiovascular Risk Markers in Polycystic Ovary Syndrome (PCOS)

Role: lead

NCT01195155Not ApplicableCompleted

Transcriptomic Profile of Adipose Tissue Following n-3 Polyunsaturated Fatty Acid (PUFA) Supplementation

Role: lead

All 8 trials loaded